PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.00 | -1.2% | 165.00 | 165.00 | 168.00 | 169.00 | 163.00 | 168.00 | 1,034,622 | 16:35:03 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -4.8 | -3.6 | - | 330 |
Synairgen (SNG) News Headlines
Synairgen News
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/2/2021 | 10:52 | ALNC |  IN BRIEF: Synairgen Begins Dosing Of Covid Patients In SNG001 Sub-Study |
| 15/2/2021 | 07:00 | UKREG | Synairgen plc Dosing commenced in US ACTIV-2 trial |
| 25/1/2021 | 19:18 | ALNC | TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic |
| 25/1/2021 | 07:00 | UKREG | Synairgen plc Inclusion in US ACTIV-2 trial |
| 20/1/2021 | 21:16 | ALNC | IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial |
| 20/1/2021 | 07:00 | UKREG | Synairgen plc Home trial recruitment completed |
| 13/1/2021 | 10:24 | ALNC | Synairgen Doses First Patient In Covid-19 Treatment Trial |
| 13/1/2021 | 07:00 | UKREG | Synairgen plc First Patient Dosing in Phase III SG018 Trial |
| 06/1/2021 | 17:10 | UKREG | Synairgen plc Holding(s) in Company |
| 05/1/2021 | 17:53 | UKREG | Synairgen plc Holding(s) in Company |
1 Year Synairgen Chart |
Intraday Synairgen Chart |
